| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | Australia | 3 | |
| #3 | United States | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pugliese Marco | 18 |
| #2 | Rodriguez Allue Manuel | 12 |
| #3 | Mahy Gehenne Josette-Nicole | 12 |
| #4 | Pasten Zamorano Andrea | 12 |
| #5 | Virgili Treserres Noemi | 12 |
| #6 | Espinosa Parrilla Juan Francisco | 12 |
| #7 | Mancera Aroca Pilar | 11 |
| #8 | Marco Pugliese | 2 |
| #9 | Allue Manuel Jose Rodriguez | 2 |
| #10 | Gehenne Josette-Nicole M | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP2422787A1 | Diazoxide for use in the treatment of amyotrophic lateral sclerosis (als) | |
| EP2343075A1 | Diazoxide for use in the treatment a central nervous system (CNS) autoimmune demyelinating disease | |
| AU2005256676A1 | Compounds for the treatment of an acute injury to the central nervous system | |
| AU2005256675A1 | Compounds for the treatment of inflammation of the central nervous system |